查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518671

2024-2032 年按产品（外用、口服、敷料）、配销通路（医院药房、零售药房、线上药房）和地区分類的放射性皮肤炎市场报告

Radiodermatitis Market Report by Product (Topical, Oral, Dressings), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球放射性皮肤炎市场规模达到4.995亿美元。

放射性皮肤炎或放射性皮肤炎是指由于用于治疗癌症的放射疗法而引起的皮肤病。它通常作为癌症治疗期间或介入放射学后的副作用出现在乳腺癌、肺癌、皮肤癌、颈部癌、头部癌或会阴区癌症患者中，其中皮肤是目标区域的一部分。治疗放射性皮肤炎的一些常用产品包括外用抗生素、皮质类固醇、亲水性乳膏、水凝胶和水胶体敷料、硅酮涂层敷料、银叶敷料、口服止痛药和抗发炎药物。近年来，放射性皮肤炎治疗受到关注，因为它有助于减轻不适、最大限度地减少疼痛并防止正在进行的治疗中断，同时提高患者的整体生活品质。

放射性皮肤炎市场趋势：

癌症的广泛流行和越来越多地采用放射治疗作为治疗选择是推动市场成长的主要因素。除此之外，全球老年人口的增加以及对抗放射治疗不良副作用的需求不断增长，都增加了对放射性皮肤炎治疗的需求。此外，许多管理和非管理机构正在采取有利倡议，以提高人们对现有放射性皮肤炎治疗和管理产品的认识。这与生命科学领域持续研发（R＆D）活动中公共和私人投资的增加相结合，正在促进市场成长。此外，领先企业正专注于开发创新产品变体，以扩大其产品组合併获得竞争优势。此外，临床试验数量的增加、有利的政府政策、消费者支出能力的提高、医疗基础设施的改善以及仿製药的容易获得是创造积极市场前景的其他因素。

本报告回答的关键问题

  • 2023年全球放射性皮肤炎市场规模有多大？
  • 2024-2032年全球放射性皮肤炎市场的预期成长率是多少？
  • COVID-19 对全球放射性皮肤炎市场有何影响？
  • 推动全球放射性皮肤炎市场的关键因素是什么？
  • 基于该产品的全球放射性皮肤炎市场的细分情况如何？
  • 根据配销通路，全球放射性皮肤炎市场的细分情况如何？
  • 全球放射性皮肤炎市场的关键区域有哪些？
  • 谁是全球放射性皮肤炎市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球放射性皮肤炎市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 专题
    • 市场走向
    • 关键环节
      • 皮质类固醇
      • 亲水霜
      • 抗生素
      • 其他的
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测
  • 敷料
    • 市场走向
    • 关键环节
      • 水凝胶和水胶体敷料
      • 无刺阻隔膜
      • 蜂蜜纱布
      • 硅胶涂层敷料
      • 其他的
    • 市场预测

第 7 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药房
    • 市场走向
    • 市场预测
  • 网路药房
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA SpA
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112024A5638

The global radiodermatitis market size reached US$ 499.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 660.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.06% during 2024-2032.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life.

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

Topical

Corticosteroids

Hydrophilic Creams

Antibiotics

Others

Oral

Dressings

Hydrogel and Hydrocolloid Dressings

No Sting Barrier Film

Honey Impregnated Gauze

Silicone Coated Dressings

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report

  • 1. What was the size of the global radiodermatitis market in 2023?
  • 2. What is the expected growth rate of the global radiodermatitis market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global radiodermatitis market?
  • 4. What are the key factors driving the global radiodermatitis market?
  • 5. What is the breakup of the global radiodermatitis market based on the product?
  • 6. What is the breakup of the global radiodermatitis market based on the distribution channel?
  • 7. What are the key regions in the global radiodermatitis market?
  • 8. Who are the key players/companies in the global radiodermatitis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiodermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11 Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players